论文部分内容阅读
作者试用重组人类α干扰素治疗10例慢性非甲非乙型肝炎(NANB),疗效令人鼓舞。病例:男9例,女1例,年龄26～62岁。全部病人符合NANB诊断标准;丙氨酸转氨酶(ALT)和天门冬氨酸转氨酶(AST)升高均超过1(1.4～9.5)
The trial of recombinant human interferon alpha treatment of 10 cases of non-non-hepatitis B non-hepatitis B (NANB), the effect is encouraging. Case: 9 males and 1 females, aged 26 to 62 years old. All patients met NANB diagnostic criteria; alanine aminotransferase (ALT) and aspartate aminotransferase (AST) increased more than 1 (1.4 ~ 9.5)